Variant report
Variant | nsv900357 |
---|---|
Chromosome Location | chr13:65156748-65215262 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:65158685..65161029-chr13:65163105..65165098,2 | MCF-7 | breast: | |
2 | chr13:65156439..65158958-chr13:65159138..65160900,2 | K562 | blood: | |
3 | chr13:65156439..65158958-chr13:65159138..65160900,2 | K562 | blood: | |
4 | chr13:65158685..65161029-chr13:65163105..65165098,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PCDH9-3 | chr13:65214335-65214785 | XLOC_010647 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530326587 | chr13:65197247-65197248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548805977 | chr13:65197313-65197314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566963836 | chr13:65197322-65197323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563055143 | chr13:65197328-65197329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs534082805 | chr13:65197338-65197339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552275987 | chr13:65197346-65197347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570578262 | chr13:65197371-65197372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34664840 | chr13:65197411-65197412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537885066 | chr13:65197443-65197444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186605747 | chr13:65197465-65197466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553495262 | chr13:65197468-65197469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138357020 | chr13:65197502-65197503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535392742 | chr13:65197521-65197522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190292132 | chr13:65197556-65197557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572291018 | chr13:65197572-65197573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9540171 | chr13:65197588-65197589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9598813 | chr13:65197594-65197595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs9598818 | chr13:65202600-65202601 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs146435162 | chr13:65202601-65202602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569371477 | chr13:65202648-65202649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs536355029 | chr13:65202691-65202692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs71442634 | chr13:65202717-65202718 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs7995923 | chr13:65202741-65202742 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs533899973 | chr13:65202771-65202772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558458303 | chr13:65202860-65202861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572996275 | chr13:65202878-65202879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192674406 | chr13:65202893-65202894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533901442 | chr13:65202895-65202896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73510844 | chr13:65202901-65202902 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs562534300 | chr13:65203014-65203015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149343323 | chr13:65203066-65203067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs369026541 | chr13:65203155-65203156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541950191 | chr13:65203178-65203179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144158445 | chr13:65203217-65203218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs527316862 | chr13:65203222-65203223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552179106 | chr13:65203252-65203253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565624273 | chr13:65203262-65203263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532685254 | chr13:65203285-65203286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551212923 | chr13:65203287-65203288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569352021 | chr13:65203306-65203307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536825327 | chr13:65203350-65203351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548289396 | chr13:65203369-65203370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566612307 | chr13:65203389-65203390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577149420 | chr13:65203396-65203397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533961490 | chr13:65203445-65203446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544488880 | chr13:65203447-65203448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558525585 | chr13:65203453-65203454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577108900 | chr13:65203472-65203473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs141750891 | chr13:65203494-65203495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556378476 | chr13:65203501-65203502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:65197200-65197600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr13:65202600-65203200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr13:65202800-65203200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr13:65203200-65208000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
5 | chr13:65203200-65208200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
6 | chr13:65208000-65208400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr13:65208000-65208600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr13:65208200-65208600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr13:65213200-65213800 | Enhancers | A549 | lung |
10 | chr13:65213200-65214800 | Enhancers | Hela-S3 | cervix |
11 | chr13:65213600-65214600 | Enhancers | Muscle Satellite Cultured Cells | -- |
12 | chr13:65213600-65214800 | Enhancers | HUVEC | blood vessel |
13 | chr13:65213800-65214800 | Flanking Active TSS | A549 | lung |
14 | chr13:65214800-65215000 | Enhancers | A549 | lung |
15 | chr13:65214800-65217600 | Weak transcription | HUVEC | blood vessel |